Sheffield Lifestyles Intervention Modality Study (SLIMS): a prospective randomised intervention trial, comparing pioglitazone with lifestyle intervention in patients with type 2 diabetes

ISRCTN	ISRCTN16339377
DOI	https://doi.org/10.1186/ISRCTN16339377
Protocol serial number	N0059108297
Sponsor	Department of Health (UK)
Funder	Sheffield Teaching Hospitals (Central Campus)

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Dr Mark Savage
Scientific

STH NHS Trust
Medicine
Diabetes/Endocrinology
Royal Hallamshire Hospital
Sheffield
S10 2JF
United Kingdom

Phone	+44 (0)114 271 2204

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Sheffield Lifestyles Intervention Modality Study (SLIMS); a prospective randomised intervention trial, comparing pioglitazone with lifestyle intervention in patients with type 2 diabetes.
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Nutritional, Metabolic, Endocrine: Diabetes
Intervention	Pioglitazone versus lifestyle intervention.
Intervention type	Other
Primary outcome measure(s)	Not provided at time of registration
Key secondary outcome measure(s)	Not provided at time of registration
Completion date	28/02/2005

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Key inclusion criteria	Patients with type 2 diabetes.
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/09/2002
Date of final enrolment	28/02/2005

STH NHS Trust

Sheffield
S10 2JF
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan